WhitTier Trust Company’s Ultragenyx Pharmaceutical RARE Stock Holding History

WhitTier Trust Company’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-70	Closed	-$3.89K	–	1392
2024 Q3	$3.89K	Hold	70	–	–	﹤0.01%	1150
2024 Q2	$2.88K	Hold	70	–	–	﹤0.01%	1139
2024 Q1	$3.27K	Hold	70	–	–	﹤0.01%	1082
2023 Q4	$3.35K	Hold	70	–	–	﹤0.01%	1081
2023 Q3	$2.49K	Hold	70	–	–	﹤0.01%	1060
2023 Q2	$3.23K	Hold	70	–	–	﹤0.01%	1070
2023 Q1	$2.81K	Hold	70	–	–	﹤0.01%	1064
2022 Q4	$3.24K	Hold	70	–	–	﹤0.01%	1054
2022 Q3	$3K	Hold	70	–	–	﹤0.01%	1020
2022 Q2	$4K	Hold	70	–	–	﹤0.01%	1023
2022 Q1	$5K	Hold	70	–	–	﹤0.01%	1010
2021 Q4	$6K	Hold	70	–	–	﹤0.01%	962
2021 Q3	$6K	Hold	70	–	–	﹤0.01%	991
2021 Q2	$7K	Hold	70	–	–	﹤0.01%	906
2021 Q1	$8K	Hold	70	–	–	﹤0.01%	879
2020 Q4	$10K	Hold	70	–	–	﹤0.01%	838
2020 Q3	$6K	Hold	70	–	–	﹤0.01%	867
2020 Q2	$5K	Hold	70	–	–	﹤0.01%	857
2020 Q1	$3K	Hold	70	–	–	﹤0.01%	919
2019 Q4	$3K	Hold	70	–	–	﹤0.01%	965
2019 Q3	$3K	Hold	70	–	–	﹤0.01%	952
2019 Q2	$4K	Hold	70	–	–	﹤0.01%	933
2019 Q1	$5K	Hold	70	–	–	﹤0.01%	911
2018 Q4	$3K	Hold	70	–	–	﹤0.01%	994
2018 Q3	$5K	Sell	70 -70	-50%	-$5.69K	﹤0.01%	872
2018 Q2	$11K	Hold	140	–	–	﹤0.01%	812
2018 Q1	$7K	Hold	140	–	–	﹤0.01%	879
2017 Q4	$6K	Hold	140	–	–	﹤0.01%	855
2017 Q3	$7K	Hold	140	–	–	﹤0.01%	827
2017 Q2	$9K	Buy	+140	New	+$8.43K	﹤0.01%	771

Other funds holding RARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

WhitTier Trust Company's RARE Position: Q4 2024 in Review

WhitTier Trust Company sold out of Ultragenyx Pharmaceutical (RARE) in Q4 2024, closing a stake of 70 shares — an estimated $3.89K sold.

WhitTier Trust Company first reported a position in RARE in Q2 2017 and held it in 30 quarters. The position peaked at $11K in Q2 2018. 313 funds tracked by Wall St. Rank hold RARE as of Q4 2024.

WhitTier Trust Company reported no remaining Ultragenyx Pharmaceutical position as of Q4 2024 after selling out during the quarter.
WhitTier Trust Company sold 70 Ultragenyx Pharmaceutical shares in Q4 2024, an estimated $3.89K.
WhitTier Trust Company first reported a position in Ultragenyx Pharmaceutical in Q2 2017 and held it in 30 quarters.
WhitTier Trust Company's Ultragenyx Pharmaceutical position peaked at $11K in Q2 2018.
313 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2024.

Based on WhitTier Trust Company's 13F filing for Q4 2024, filed 11 Feb 2025.